TipRanks
Go Ultimate55% OFF

Rocket Doctor AI (9390) Stock Price & Analysis

9390 Stock Chart & Stats

€0.28-€0.01(-3.16%)
At close: 5:30 PM GMT+1
EUR 0.3EUR 0.325EUR 0.35EUR 0.37510 Aug28 Aug14 Sep30 Sep7 Oct29 Oct
Day’s Range
EUR 0.27 - EUR 0.28
52-Week Range
EUR 0.27 - EUR 0.55
Previous Close
EUR 0.29
Volume
0
Average Volume (3M)
559
Market Cap
EUR 28.45M
Enterprise Value
EUR 58.25M
Total Cash (Recent Filing)
EUR 947.65K
Total Debt (Recent Filing)
EUR 1.20M
Price to Earnings (P/E)
―
Beta
0.59
Next Earnings
Dec 01, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Rapid Revenue Scaling

Revenue is scaling rapidly from a small base, indicating that Rocket Doctor AI is expanding commercial activity and gaining adoption for its offerings. If this growth persists, a larger revenue base could improve operating leverage and provide greater capacity to fund product development and care delivery.

Virtual Care Platform

The virtual-care model provides a scalable way to connect patients and licensed clinicians without relying solely on in-person delivery. Its digital structure can support broader access and recurring platform activity, while the clinical workflow focus extends the company beyond a single telemedicine use case.

AI-Enabled Clinical Workflows

AI-enabled workflow tools give Rocket Doctor AI a second avenue for expansion alongside direct virtual consultations. Embedding software into clinical processes can deepen the platform’s role with providers and create a more durable technology offering as digital health adoption develops.

Bears Say

Persistent Unprofitability

The company has not yet demonstrated a profitable operating model: losses remain very large relative to revenue, and even gross profit is slightly negative on a trailing basis. Without meaningful margin improvement, future revenue growth may continue to require substantial funding rather than translate into durable earnings.

Sustained Cash Burn

Ongoing negative operating and free cash flow indicate that the business is consuming substantial cash to support operations. Continued burn can restrict investment flexibility and increase reliance on external financing, making financial stability dependent on improving cash conversion over the coming quarters.

Balance Sheet Deterioration

Leverage has risen sharply as equity declined, leaving a materially thinner capital cushion while the company continues to report losses. Higher debt relative to equity reduces financial flexibility, increases the consequences of further operating shortfalls, and may constrain funding choices for growth.

Rocket Doctor AI News

9390 FAQ

What was Rocket Doctor AI’s price range in the past 12 months?
Rocket Doctor AI lowest stock price was €0.27 and its highest was €0.55 in the past 12 months.
What is Rocket Doctor AI’s market cap?
Rocket Doctor AI’s market cap is €28.45M.
When is Rocket Doctor AI’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Rocket Doctor AI’s earnings last quarter?
Rocket Doctor AI released its earnings results on Aug 31, 2026. The company reported -€0.045 earnings per share for the quarter.
Is Rocket Doctor AI overvalued?
According to Wall Street analysts Rocket Doctor AI’s price is currently Undervalued.
Does Rocket Doctor AI pay dividends?
Rocket Doctor AI does not currently pay dividends.
What is Rocket Doctor AI’s EPS estimate?
Rocket Doctor AI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rocket Doctor AI have?
Rocket Doctor AI has 101,262,250 shares outstanding.
What happened to Rocket Doctor AI’s price movement after its last earnings report?
Rocket Doctor AI reported an EPS of -€0.045 in its last earnings report. Following the earnings report the stock price went down -1.408%.
Which hedge fund is a major shareholder of Rocket Doctor AI?
Currently, no hedge funds are holding shares in DE:9390
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology